Home Tags Sexually Transmitted Diseases: AIDS/HIV

Tag: Sexually Transmitted Diseases: AIDS/HIV

May 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2020. This roundup includes...
Many sexually active men who have sex with men do not receive recommended prevention services and sexually transmitted disease testing when receiving care for HIV infection

HIV+ Men Are Not Receiving STD Testing, Prevention Services

Men receiving HIV care still not receiving guideline-recommended sexually transmitted disease testing

April 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2020. This roundup includes...
For people with substance use disorders

Bundled Rapid HIV/Hep C Testing May Improve Infection Awareness

Bundled HIV, hepatitis C testing ups number of people with substance use disorders aware of infection status
Greater alcohol consumption is associated with lower serum levels of bone formation markers among patients living with HIV and substance use disorder

Higher Alcohol Intake May Harm Bone Health in HIV Patients

Alcohol intake tied to levels of bone turnover markers in patients with HIV and substance use disorder

March 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for March 2020. This roundup includes...
Amongpatients with multidrug-resistant HIV-1 infection who have limited therapy options

Fostemsavir Active in Multidrug-Resistant HIV-1 Infection

Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort
A second case of HIV-1 cure following allogeneic hemopoietic stem cell transplantation has been reported at 30 months after analytical treatment interruption

Second Case of HIV-1 Cure After Stem Cell Transplant Reported

HIV-1 viral load remained undetectable in plasma in patient up to 30 months after transplant
Use of tenofovir alafenamide-emtricitabine is not cost-effective compared with generic tenofovir disoproxil fumarate-emtricitabine for HIV preexposure prophylaxis among men who have sex with men

New HIV PrEP Drug Not Cost-Effective Compared With Generic

F/TAF would avert 2,101 fractures, 25 cases of end-stage renal disease, but not deemed cost-effective
For patients with HIV-1 suppression

Long-Acting Cabotegravir, Rilpivirine Noninferior in HIV-1

Studies demonstrate noninferiority to standard oral therapy, dolutegravir-abacavir-lamivudine